The design of membrane-controlled transdermal therapeutic systems containing molsidomine.
M
M
Yamada
Y
Y
Tanigawara
D000279:Administration, Cutaneous; D000818:Animals; D008297:Male; D008567:Membranes, Artificial; D008981:Molsidomine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051381:Rats; D011919:Rats, Inbred Strains
D008567:Membranes, Artificial; D008981:Molsidomine